BTK Inhibitors in CLL and Lymphomas: Overview and Current Indications
- Author
- Clinical Care Options, LLC
- Published
- Fri 23 Jul 2021
- Episode Link
- https://oncologypodcast.simplecast.com/episodes/ned-talk-btki-overview-tDiDD2RH
In this podcast episode, Beth Faiman, PhD, MSN, APRN-BC, AOCN, provides a nursing-focused overview on available BTK inhibitors in the treatment of CLL and lymphomas. Topics in this podcast include:
- Rationale for inhibiting BTK
- MOA of BTK inhibitors
- Approved BTK inhibitors
- Recent clinical trial findings
Link to full program, including downloadable slidesets:
https://bit.ly/3iwN9Ub
Presenter:
Beth Faiman, PhD, MSN, APRN-BC, AOCN
Nurse Practitioner
Cleveland Clinic Taussig Cancer Institute
Cleveland, Ohio
